Ganymed Pharmaceuticals GmbH;TRON - Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg
发明人:
Ugur Sahin,Ozlem Tureci,Daniel Maurus
申请号：
US15565306
公开号：
US20180073077A1
申请日:
2016.04.13
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention generally relates to methods and compositions for the prediction of therapeutic efficacy of cancer treatments and the prognosis of cancer. The invention discloses markers that are associated with favorable and unfavorable outcomes, respectively, in certain cancer treatments and are useful as prognostic markers for cancer. Methods involving these markers are disclosed for predicting cancer therapy benefit and prognosing clinical outcome for cancer patients.
